- Associate Professor, Department of Neurology
- Northwestern University, Feinberg School of Medicine
- Faculty, Chemistry of Life Processes Institute
- Faculty, Les Turner ALS Center
- Faculty, Cognitive Neurology and Alzheimer’s Disease Center
- Faculty, Robert H. Lurie Comprehensive Cancer Research Center
Dr. Ozdinler, Ph.D., is an Associate Professor of Neurology and received training in the fields of molecular biology and genetics (BS- Bogazici University), biotechnology and chemical engineering (MS-Bogazici University), and earned PhD in the fields of cell biology, anatomy, and neuroscience (LSU Health Sciences Center). She then joined the Neurosurgery Department at MGH (postdoctoral fellow- Harvard Medical School), and received the Harvard NeuroDiscovery fellowship (HCNR). She became the founding director of the second Les Turner ALS Laboratory at Northwestern, which focuses on the biology and pathology of upper motor neurons (UMNs). She is the recipient of NUCATS Translational Innovation and CLP Cornew Innovation awards. Her research is focused on the improvement of the health of diseased UMNs and identification of biomarkers that inform on the timing and extent of UMN loss. She is also a faculty member of the Chemistry Life Sciences Processes Institute, Les Turner ALS Center, Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, and Robert H. Lurie Comprehensive Cancer Research Center. She is the Scientific Director of A Long Swim, and her research is funded by NIH, NIA, and numerous foundations.
- Associate Professor, Department of Neurology
- Northwestern University, Feinberg School of Medicine
- Faculty, Chemistry of Life Processes Institute
- Faculty, Les Turner ALS Center
- Faculty, Cognitive Neurology and Alzheimer’s Disease Center
- Faculty, Robert H. Lurie Comprehensive Cancer Research Center
Dr. Ozdinler, Ph.D., is an Associate Professor of Neurology and received training in the fields of molecular biology and genetics (BS- Bogazici University), biotechnology and chemical engineering (MS-Bogazici University), and earned PhD in the fields of cell biology, anatomy, and neuroscience (LSU Health Sciences Center). She then joined the Neurosurgery Department at MGH (postdoctoral fellow- Harvard Medical School), and received the Harvard NeuroDiscovery fellowship (HCNR). She became the founding director of the second Les Turner ALS Laboratory at Northwestern, which focuses on the biology and pathology of upper motor neurons (UMNs). She is the recipient of NUCATS Translational Innovation and CLP Cornew Innovation awards. Her research is focused on the improvement of the health of diseased UMNs and identification of biomarkers that inform on the timing and extent of UMN loss. She is also a faculty member of the Chemistry Life Sciences Processes Institute, Les Turner ALS Center, Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, and Robert H. Lurie Comprehensive Cancer Research Center. She is the Scientific Director of A Long Swim, and her research is funded by NIH, NIA, and numerous foundations.
Hiroshi Mitsumoto, MD, D.Sc., has been the Wesley J. Howe Professor of Neurology at Columbia University Medical Center since 1999 and the Director Emeritus (since 2019) of the MDA/ALS Clinical Research Center. In 1968, he graduated at the top of his class from Toho University School of Medicine, Tokyo. From 1972, he pursued further medical and neurology training at Johns Hopkins University, Case Western Reserve University, Cleveland Clinic, and Tufts University. In 1983, he established the ALS Clinic at Cleveland Clinic, one of the first such multidisciplinary ALS Clinics in the country and began working at the Cleveland Clinic as the Director of the Neuromuscular Section and ALS Center. He has since been involved with extensive research in ALS, including improving patient care/management and end of life issues, multiple clinical trials, biomarker development, and multisite epidemiological studies. He organized several large national and international ALS Conferences and is currently updating and developing the new International ALS Clinical Trial Guidelines. He was a member of Steering Committee of several clinical trials in ALS and served as a Chair of ALS Association Medical Advisory Board and Chair of ALS Center Certification Committee for ALS Association. He received the Donald C. Mulder Award for achievement, leadership, and dedication in ALS from ALS Association in 1996, the Forbes H. Norris Award for Compassion and Love for Humanity in Research and Treatment in Patients with ALS from the International ALS Symposium and International ALS Alliance in 1998, Lou Gehrig Memorial Award from the MDA in 2000, and Diamond Award from the MDA Wings Over Wall Street in 2002. He has published more than 200 articles in peer-reviewed journals, mostly in ALS, in addition to reviews, chapters, and books. He has been named one of the Best Doctors in America since 1996 and America’s Top Doctors for the past several years. One of his edited books, ALS: A Guide for Patients and Families, is currently in its 3rd edition. For more than a decade, his research interests have expanded to PLS.
Hiroshi Mitsumoto, MD, D.Sc., has been the Wesley J. Howe Professor of Neurology at Columbia University Medical Center since 1999 and the Director Emeritus (since 2019) of the MDA/ALS Clinical Research Center. In 1968, he graduated at the top of his class from Toho University School of Medicine, Tokyo. From 1972, he pursued further medical and neurology training at Johns Hopkins University, Case Western Reserve University, Cleveland Clinic, and Tufts University. In 1983, he established the ALS Clinic at Cleveland Clinic, one of the first such multidisciplinary ALS Clinics in the country and began working at the Cleveland Clinic as the Director of the Neuromuscular Section and ALS Center. He has since been involved with extensive research in ALS, including improving patient care/management and end of life issues, multiple clinical trials, biomarker development, and multisite epidemiological studies. He organized several large national and international ALS Conferences and is currently updating and developing the new International ALS Clinical Trial Guidelines. He was a member of Steering Committee of several clinical trials in ALS and served as a Chair of ALS Association Medical Advisory Board and Chair of ALS Center Certification Committee for ALS Association. He received the Donald C. Mulder Award for achievement, leadership, and dedication in ALS from ALS Association in 1996, the Forbes H. Norris Award for Compassion and Love for Humanity in Research and Treatment in Patients with ALS from the International ALS Symposium and International ALS Alliance in 1998, Lou Gehrig Memorial Award from the MDA in 2000, and Diamond Award from the MDA Wings Over Wall Street in 2002. He has published more than 200 articles in peer-reviewed journals, mostly in ALS, in addition to reviews, chapters, and books. He has been named one of the Best Doctors in America since 1996 and America’s Top Doctors for the past several years. One of his edited books, ALS: A Guide for Patients and Families, is currently in its 3rd edition. For more than a decade, his research interests have expanded to PLS.
Jinsy A. Andrews, M.D., M.Sc. currently serves as the Director of Neuromuscular Clinical Trials at Columbia University. In addition to overseeing neuromuscular clinical trials, she cares for people with neuromuscular disorders, primarily with amyotrophic lateral sclerosis (ALS). She is the co-chair of the Northeastern ALS Consortium (NEALS) which is a network of over 130 ALS clinical centers and is also a national Board of Trustee for the ALS Association. She is also a Fellow of the American Academy of Neurology (AAN) and serves on the AAN Science Committee.
Dr. Andrews received her B.S. from Union College, her M.Sc. in Biostatistics (Patient-Oriented Research) from Columbia University’s Mailman School of Public Health, and her M.D. from Albany Medical College. Dr. Andrews completed her residency in Neurology at the University of Connecticut and completed fellowship training in both Neuromuscular Medicine and Clinical Neurophysiology at Columbia. Dr. Andrews is board certified in Neurology, Neuromuscular Disease, and Electrodiagnostic Medicine.
Jinsy A. Andrews, M.D., M.Sc. currently serves as the Director of Neuromuscular Clinical Trials at Columbia University. In addition to overseeing neuromuscular clinical trials, she cares for people with neuromuscular disorders, primarily with amyotrophic lateral sclerosis (ALS). She is the co-chair of the Northeastern ALS Consortium (NEALS) which is a network of over 130 ALS clinical centers and is also a national Board of Trustee for the ALS Association. She is also a Fellow of the American Academy of Neurology (AAN) and serves on the AAN Science Committee.
Dr. Andrews received her B.S. from Union College, her M.Sc. in Biostatistics (Patient-Oriented Research) from Columbia University’s Mailman School of Public Health, and her M.D. from Albany Medical College. Dr. Andrews completed her residency in Neurology at the University of Connecticut and completed fellowship training in both Neuromuscular Medicine and Clinical Neurophysiology at Columbia. Dr. Andrews is board certified in Neurology, Neuromuscular Disease, and Electrodiagnostic Medicine.